Episode 447 -- Veloxis Pharmaceuticals' $46 Million Kickback Settlement and What the CEP Really Rewards

Corruption Crime & Compliance by Michael Volkov

Sep 6, 20267:18Business

In this episode of Corruption, Crime and Compliance, Michael Volkov breaks down Veloxis Pharmaceuticals' more than $46 million settlement with DOJ and HHS-OIG over a years-long kickback scheme involving its kidney transp...

Related Episodes

Continue listening to more episodes from Corruption Crime & Compliance.

Can You Get Off the SDN List?

Sep 10, 2026 - 1:46

Has OFAC branded your company with the scarlet letter? Getting removed from the SDN list is possible, but...

Episode 448: Caremark in 2026 — Where Delaware Draws the Line Between Bad Judgment and Bad Faith

Sep 9, 2026 - 11:46

In this episode of Corruption, Crime and Compliance, Michael Volkov examines how Delaware's Caremark doct...

Is Your Sanctions Screening Enough?

Sep 8, 2026 - 1:54

Are you rubbing elbows with criminals? When OFAC designates someone a specially designated national, or S...

When You Fail to Fix an Already Flagged Compliance Gap

Sep 3, 2026 - 1:54

At $125 million, breaking the law can never be a cost of doing business. UBS Bank was hit with a $125 mil...

Episode 446 -- L3Harris's CEO Ouster and the Board Governance Lesson Nobody Learns the First Time

Sep 1, 2026 - 8:28

In this episode of Corruption, Crime and Compliance, Michael Volkov examines L3Harris Technologies' abrup...

Could Your Routine Customs Payment Actually Be a Bribe?

Sep 1, 2026 - 1:43

Is your routine payment actually a bribe? Scolar, an Omaha agricultural company, resolved an FCPA case fo...

Episode 445 -- Why Your Organization Needs an AI Acceptable Use Policy

Aug 30, 2026 - 9:25

In this episode of Corruption, Crime and Compliance, Michael Volkov makes the case that every organizatio...

Can Your Biggest FCPA Risk Be a Trusted Insider?

Aug 27, 2026 - 1:44

Have you heard about the Goldman Sachs banker who bribed his way to a conviction? A federal jury in Brook...